Skip to main content
AMPH
NASDAQ Life Sciences

Board Authorizes $50M Increase to Share Buyback Program

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$18.18
Mkt Cap
$824.83M
52W Low
$17.03
52W High
$31.264
52W Position info
6.8% above low
Off High info
42% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

AMPH is trading near its 52-week low of $17.03 (6.8% above the low).

Summary

Amphastar Pharmaceuticals' Board of Directors has authorized a $50 million increase to its existing share buyback program, primarily to offset dilution from equity compensation.


Key Events · Financing and Capital Events · AMPH

  • Share Buyback Program Expanded

    The Board of Directors authorized a $50 million increase to the company's existing share repurchase program on March 12, 2026.

  • Strategic Rationale

    The primary goal of the share buyback program is to offset dilution created by the company's equity compensation programs.

  • Program Details

    Purchases may be made through open market and private block transactions, including Rule 10b5-1 plans, and are expected to continue for an indefinite period.


Analysis · AMPH · Life Sciences

Amphastar Pharmaceuticals' Board of Directors has authorized a significant $50 million increase to its existing share repurchase program. This expansion, representing over 6% of the company's current market capitalization, signals management's confidence in the company's valuation and its commitment to mitigating dilution from equity compensation. Such a move is generally viewed positively by investors as it can support earnings per share and demonstrates a proactive capital allocation strategy.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMPH was trading at $18.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $824.8M. The 52-week trading range was $17.03 to $31.26. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMPH - Latest Insights

AMPH
Aug 06, 2026, 4:50 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.35
Real-time Price: $25.43 info
Change: +$5.08 (+25%) info
Market Cap: $1.082B info
AMPH
Aug 06, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $20.35
Real-time Price: $25.43 info
Change: +$5.08 (+25%) info
Market Cap: $1.082B info
AMPH
Jul 13, 2026, 7:20 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $18.72
Real-time Price: $25.43 info
Change: +$6.71 (+36%) info
Market Cap: $1.082B info
AMPH
Jul 08, 2026, 6:03 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $20.00
Real-time Price: $25.43 info
Change: +$5.43 (+27%) info
Market Cap: $1.082B info
AMPH
Jul 07, 2026, 8:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.00
Real-time Price: $25.43 info
Change: +$5.43 (+27%) info
Market Cap: $1.082B info